魏淑青++史宇霞



[摘要]目的 研究胸腺肽注射液辅助化疗对卵巢癌患者CD3+、CD4+、NK细胞等指标的影响。方法 2013年7月~2016年8月,选取我院收治的卵巢癌患者98例进行研究。以数字法将所有患者分为观察组、对照组,每组49例。观察组患者实施胸腺肽注射液辅助化疗治疗,对照组实施化疗,比较两组患者的CD3+、CD4+、NK细胞水平等指标。结果 治疗后,观察组的优良率为95.92%,显著高于对照组的79.59%,差异有统计学意义(P<0.05)。治疗后,观察组的CD3+、CD4+、NK细胞水平均显著高于对照组,差异有统计学意义(P<0.01)。与治疗前比较,两组治疗后的白细胞计数、中性粒细胞计数以及血红蛋白数量均有所下降,且观察组白细胞计数、中性粒细胞计数的改善程度显著优于对照组,差异有统计学意义(P<0.01)。结论 胸腺肽注射液辅助化疗对卵巢癌患者进行治疗,能够有效改善CD3+、CD4+、NK细胞水平,调节患者外周血象水平,提高治疗效果。
[关键词]胸腺肽注射液;化疗;卵巢癌;CD3+;CD4+
[中图分类号] R737.31 [文献标识码] A [文章编号] 1674-4721(2017)06(b)-0063-03
[Abstract]Objective To study the influence of Thymopeptide Enteric Injection adjuvant chemotherapy on CD3+,CD4+,NK cell level in patients with ovarian cancer.Methods From July 2013 to August 2016,98 patients with ovarian carcinoma treated in our hospital were studied,and they were divided into observation group and control group by using digital method,and there were 49 cases in each group.The patients in the observation group were given Thymopeptide Enteric Injection adjuvant chemotherapy,while the control group was given chemotherapy.CD3+,CD4+,NK cell level and so on between two groups were compared.Results After treatment,the excellent and good rate of the observation group was 95.92%,which was significantly higher than that of the control group (79.59%),and the difference was statistically significant (P<0.05).After treatment,the level of CD3+,CD4+,and NK in the observation group were significantly higher than those in the control group,the difference was statistically significant (P<0.01).Compared with before treatment,he white blood cell count,neutrophil count and the number of hemoglobin decreased in the two groups,and the improvement degree of WBC count and neutrophil count in the observation group was significantly better than that in the control group,the difference was statistically significant (P<0.01).Conclusion Thymopeptide Enteric Injection adjuvant chemotherapy treating patients with ovarian cancer can improve effectively CD3+,CD4+,and NK cell level,regulate the peripheral hemogram of the patients,improve the therapeutic effect.
[Key words]Thymopeptide Enteric Injection;Chemotherapy;Ovarian cancer;CD3+;CD4+
因為卵巢的胚胎发育,组织解剖以及内分泌功能较为复杂,卵巢所患肿瘤或许是良性,也或许是恶性。由于卵巢癌临床早期无症状,鉴别其组织类型以及良恶性相当困难,卵巢癌实施剖腹探查术中发现肿瘤局限于卵巢的仅占30%,大多数已经扩散到子宫双侧附件,大网膜以及盆腔各器官,因此卵巢癌不管在诊断以及治疗上确实成为一大难题。多年来专家们对卵巢恶性肿瘤的病理形态,临床发生、发展规律以及治疗方案进行了较多的探讨,积累了许多经验[1-3]。现如今,就国内外的临床资料统计,卵巢癌5年生存率仅为25%~30% 。卵巢癌是相对多见的病症,大约有1.4%的女性会患上此种病症。然而如果发现较早,90%的患者可以活下来;发现较晚,癌细胞扩散到卵巢,存活率就<30%。本研究探讨胸腺肽注射液辅助化疗对卵巢癌患者CD3+、CD4+、NK细胞水平等指标的影响,旨在为临床治疗提供相应的数据支持,现报道如下。
1 资料與方法
1.1一般资料……p>